You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mutation Asp-816-Val(D816V)

Showing 1 - 25 of 3,167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

(PROSPECTOR) Screening Study Evaluating Prevalence of KIT D816V

Recruiting
  • Systemic Mast Cell Activation
  • KIT D816V Mutation
  • Screening
  • Boston, Massachusetts
  • +1 more
May 5, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Mastocytosis Trial (masitinib)

Completed
  • Mastocytosis
  • (no location specified)
Dec 6, 2018

Mastocytosis Trial (masitinib (AB1010))

Completed
  • Mastocytosis
  • masitinib (AB1010)
  • (no location specified)
Dec 8, 2018

Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

Recruiting
  • Indolent Systemic Mastocytosis
  • Rochester, Minnesota
  • +6 more
Nov 29, 2021

Lentigo Solar, Senile Lentigo Trial in Batumi (Prototypes (816-v1 301) to (816-v1 355) every week, Prototypes (816-v1 301) to

Not yet recruiting
  • Lentigo Solar
  • Senile Lentigo
  • Prototypes (816-v1 301) to (816-v1 355) every week
  • Prototypes (816-v1 301) to (816-v1 355) every two weeks
  • Batumi, Georgia
    Ltd "Health"
Mar 31, 2023

Solar Lentigo, Senile Lentigo, Post Inflammatory Hyperpigmentation Trial in Pretoria (Condition 1 : Prototypes (816-v1) every

Not yet recruiting
  • Solar Lentigo
  • +2 more
  • Condition 1 : Prototypes (816-v1) every weeks
  • Condition 2 : Prototypes (816-v1) every two weeks
  • Pretoria, Gauteng, South Africa
    Photobiology Laboratory, Sefako Makgatho Health Sciences Univers
May 22, 2023

Solar Lentigo, Senile Lentigo, Post-inflammatory Hyperpigmentation Trial in Pretoria (Prototypes (816-v1 001) to (816-v1 050),

Not yet recruiting
  • Solar Lentigo
  • +2 more
  • Prototypes (816-v1 001) to (816-v1 050)
  • +3 more
  • Pretoria, South Africa
    SMU - Photobiology Laboratory, Sefako Makgatho Health Sciences U
Nov 18, 2022

First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

Completed
  • BRAF V600E Mutation Positive
  • Metastatic Colorectal Cancer
  • Non Interventional study
  • St. Veit/Glan, Austria
  • +33 more
Jan 20, 2023

Relapsed AML, T(8;21), C-KIT Mutation Trial in Tianjin (Dasatinib)

Withdrawn
  • Relapsed AML
  • +2 more
  • Tianjin, Tianjin, China
    HBDH
Mar 19, 2020

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Lung Cancer Trial in Boston (EGF816, Gefitinib)

Active, not recruiting
  • Lung Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 21, 2022

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Advanced Solid Tumors Trial in Worldwide (Olaparib)

Recruiting
  • Advanced Solid Neoplasms
  • Tucson, Arizona
  • +128 more
Aug 18, 2022

Neonates Trial in China (Collaborative Antimicrobial Stewardship Program (ASP))

Recruiting
  • Neonates
  • Collaborative Antimicrobial Stewardship Program (ASP)
  • Fuzhou, Fujian, China
  • +25 more
Oct 24, 2022

Indolent Systemic Mastocytosis Trial in France, United States (Masitinib, Placebo, Best Supportive Care)

Completed
  • Indolent Systemic Mastocytosis
  • Sacramento, California
  • +23 more
Nov 29, 2019

Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

Active, not recruiting
  • Advanced Systemic Mastocytosis
  • +3 more
  • Stanford, California
  • +31 more
Mar 25, 2022

Cause of Unexplained Anaphylaxis

Recruiting
  • Idiopathic Anaphylaxis
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 12, 2023

    Atrial Fibrillation, Hemostasis Trial in Overland Park, Independence, Kansas City (Vascular closure with LockeT device)

    Recruiting
    • Atrial Fibrillation
    • Hemostasis
    • Vascular closure with LockeT device
    • Overland Park, Kansas
    • +5 more
    Oct 3, 2023

    Indolent Systemic Mastocytosis Trial in Worldwide (Avapritinib, Placebo)

    Active, not recruiting
    • Indolent Systemic Mastocytosis
    • Birmingham, Alabama
    • +48 more
    Jan 19, 2022

    Formulary Coverage of Entresto on Prescription

    Completed
    • Chronic Heart Failure
      • Durham, North Carolina
        IQVIA
      Apr 27, 2023

      Biomechanics Based Prediction of Preterm Delivery

      Completed
      • Preterm Delivery
      • Pregnolia System
      • Leuven, Belgium
      • +12 more
      Dec 8, 2022

      SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)

      Recruiting
      • SSM
      • +3 more
      • CGT9486 Tablets
      • Placebo Tablets
      • Clearwater, Florida
      • +5 more
      Apr 14, 2022

      Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in

      Recruiting
      • Advanced Systemic Mastocytosis (AdvSM)
      • +3 more
      • CGT9486 tablets
      • Duarte, California
      • +10 more
      Jul 8, 2022